231 related articles for article (PubMed ID: 28369083)
21. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Meierjohann S; Walter RD; Müller S
Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
[TBL] [Abstract][Full Text] [Related]
22. Spinning disk confocal microscopy of live, intraerythrocytic malarial parasites. 2. Altered vacuolar volume regulation in drug resistant malaria.
Gligorijevic B; Bennett T; McAllister R; Urbach JS; Roepe PD
Biochemistry; 2006 Oct; 45(41):12411-23. PubMed ID: 17029397
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor reduces Plasmodium falciparum growth and activates calcium signaling in human malaria parasites.
Cruz LN; Wu Y; Ulrich H; Craig AG; Garcia CR
Biochim Biophys Acta; 2016 Jul; 1860(7):1489-97. PubMed ID: 27080559
[TBL] [Abstract][Full Text] [Related]
24. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
[TBL] [Abstract][Full Text] [Related]
25. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase.
Famin O; Ginsburg H
Parasite; 2003 Mar; 10(1):39-50. PubMed ID: 12669348
[TBL] [Abstract][Full Text] [Related]
26. In vivo imaging of H2O2 production in Drosophila.
Barata AG; Dick TP
Methods Enzymol; 2013; 526():61-82. PubMed ID: 23791094
[TBL] [Abstract][Full Text] [Related]
27. Real-time quantification of subcellular H
Panieri E; Millia C; Santoro MM
Free Radic Biol Med; 2017 Aug; 109():189-200. PubMed ID: 28192232
[TBL] [Abstract][Full Text] [Related]
28. Growth inhibitory effects of standard pro- and antioxidants on the human malaria parasite Plasmodium falciparum.
Wezena CA; Krafczyk J; Staudacher V; Deponte M
Exp Parasitol; 2017 Sep; 180():64-70. PubMed ID: 28242353
[TBL] [Abstract][Full Text] [Related]
29. Antimalarial drugs disrupt ion homeostasis in malarial parasites.
Gazarini ML; Sigolo CA; Markus RP; Thomas AP; Garcia CR
Mem Inst Oswaldo Cruz; 2007 Jun; 102(3):329-34. PubMed ID: 17568938
[TBL] [Abstract][Full Text] [Related]
30. Live Monitoring of ROS-Induced Cytosolic Redox Changes with roGFP2-Based Sensors in Plants.
Ugalde JM; Fecker L; Schwarzländer M; Müller-Schüssele SJ; Meyer AJ
Methods Mol Biol; 2022; 2526():65-85. PubMed ID: 35657512
[TBL] [Abstract][Full Text] [Related]
31. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
Biot C; Dessolin J; Grellier P; Davioud-Charvet E
Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
[TBL] [Abstract][Full Text] [Related]
32. Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages.
Ockenhouse CF; Schulman S; Shear HL
J Immunol; 1984 Sep; 133(3):1601-8. PubMed ID: 6431003
[TBL] [Abstract][Full Text] [Related]
33. Effect of antimalarial drugs on Plasmodium falciparum gametocytes.
Peatey CL; Skinner-Adams TS; Dixon MW; McCarthy JS; Gardiner DL; Trenholme KR
J Infect Dis; 2009 Nov; 200(10):1518-21. PubMed ID: 19848586
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development.
Stack CM; Lowther J; Cunningham E; Donnelly S; Gardiner DL; Trenholme KR; Skinner-Adams TS; Teuscher F; Grembecka J; Mucha A; Kafarski P; Lua L; Bell A; Dalton JP
J Biol Chem; 2007 Jan; 282(3):2069-80. PubMed ID: 17107951
[TBL] [Abstract][Full Text] [Related]
35. Loss of pH control in Plasmodium falciparum parasites subjected to oxidative stress.
van Schalkwyk DA; Saliba KJ; Biagini GA; Bray PG; Kirk K
PLoS One; 2013; 8(3):e58933. PubMed ID: 23536836
[TBL] [Abstract][Full Text] [Related]
36. Role and Regulation of Glutathione Metabolism in Plasmodium falciparum.
Müller S
Molecules; 2015 Jun; 20(6):10511-34. PubMed ID: 26060916
[TBL] [Abstract][Full Text] [Related]
37. Uptake of proteins and degradation of human serum albumin by Plasmodium falciparum-infected human erythrocytes.
El Tahir A; Malhotra P; Chauhan VS
Malar J; 2003 May; 2():11. PubMed ID: 12801422
[TBL] [Abstract][Full Text] [Related]
38. The Malaria Parasite's Lactate Transporter PfFNT Is the Target of Antiplasmodial Compounds Identified in Whole Cell Phenotypic Screens.
Hapuarachchi SV; Cobbold SA; Shafik SH; Dennis AS; McConville MJ; Martin RE; Kirk K; Lehane AM
PLoS Pathog; 2017 Feb; 13(2):e1006180. PubMed ID: 28178359
[TBL] [Abstract][Full Text] [Related]
39. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
40. Validation of a Plasmodium falciparum parasite transformed with green fluorescent protein for antimalarial drug screening.
Sanchez BA; Varotti FP; Rodrigues FG; Carvalho LH
J Microbiol Methods; 2007 Jun; 69(3):518-22. PubMed ID: 17466399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
